Trial reportDevelopmental science2026
The Kia Tīmata Pai Randomized Controlled Trial: ENRICH Early Childhood Teacher Training Improves Toddlers' Oral Language and Self-Regulation.
Trial report in Developmental science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Children's oral language and self-regulation skills are critical for healthy development and life trajectories. ENRICH is a preventive intervention developed for early childhood teachers to enhance these skills in toddlers. Kia Tīmata Pai (Best Start study) is a longitudinal cluster randomized controlled trial in 136 New Zealand early childhood education centers testing the impact of ENRICH with 1875 teachers on 1481 toddlers' (M = 20.6 months at recruitment; 72% European, 24% Māori, 23% Asian, 9% Pacific using a total response method; 7% low-SES, 40% middle-SES, 53% high-SES) oral language and self-regulation skills. After 18 months, ENRICH produced benefits for children's oral language and self-regulation skills (parent and teacher ratings) and for early literacy and social skills (teacher ratings) compared to an active control condition. Oral language benefits (parent ratings) emerged earlier for children from low- and mid-socioeconomic (SES) families and whose mothers had lower educational qualifications. Benefits for oral language and self-regulation skills at age 3 held regardless of children's SES, ethnicity, bilingual status, initial language level, age, and maternal education. Benefits for oral language at age 3 were moderated by child sex and differed by informant, with teachers perceiving greater ENRICH benefits for boys, and parents for girls. The likely mechanism of ENRICH's effects is through sensitive serve-and-return interactions that support children's oral language and attention skills. ENRICH is a potentially powerful tool for supporting toddlers' language, cognitive, and socioemotional development with possible downstream effects for academic achievement, health, and well-being. A video abstract of this article can be viewed at https://youtu.be/iIV1l0-cKIo. SUMMARY: ENRICH is a new oral language preventive intervention designed for early childhood education teachers of toddlers based on serve-and-return and rich conversations across the day. A longitudinal cluster randomized controlled trial showed that ENRICH improved toddlers' oral language, self-regulation, emergent literacy, and social skills compared to an active control condition. Oral language benefits emerged earlier for toddlers from low- and middle-socioeconomic status (SES) families and whose mothers had lower educational qualifications. Benefits for oral language and self-regulation skills at age 3 held regardless of children's SES, maternal education, ethnicity, bilingual status, initial language level, and age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.